About

CAPTURE MORE BREAST CANCERS EARLY – SIMPLE, PAINLESS AND ACCURATE

For fifty (50) years, the best defense women had against breast cancer was early detection with annual mammograms – which aren’t available for most women under 40 and miss 20% of breast cancers. 

Join the early detection revolution! We are committed to practically painless, equitably available, hyper-sensitive breast cancer screening through a simple blood draw.

The PiNK Test is the result of breakthrough academic research from USC INTERCEPT led by Professor Dr. Peter Kuhn to discover more effective ways to detect breast cancers, like his mother’s, much earlier. Combining an interdisciplinary team in cancer research, data science, AI, clinical care, and more, the PiNK Test, with its partner smartphone digital health tools from Cansera, will make breast cancer screening accessible for all women with access to a blood draw. 

The early detection revolution aims to detect all breast cancers when they are 99% successfully treatable while simultaneously reducing the 4.5 million unnecessary and anxiety-inducing biopsies for false positive suspicious findings. The PiNK Test will save over 11,000 lives and an estimated $13.5 billion in the United States alone. Using cutting-edge AI to match images from a blood draw to unique patterns of women’s breast cancer, early published research of the PiNK Test shows 99% sensitivity and specificity.

Join our revolution – let’s save more women’s lives. 

• Donate $10 to expedite clinical testing of the PiNK Test
• Join the PiNK Test Community to stay abreast of scientific developments and availability